Literature DB >> 7623824

DNA ligase I mediates essential functions in mammalian cells.

J H Petrini1, Y Xiao, D T Weaver.   

Abstract

DNA replication, repair, and recombination are essential processes in mammalian cells. Hence, the application of gene targeting to the study of these DNA metabolic pathways requires the creation of nonnull mutations. We have developed a method for introducing partially defective mutants in murine embryonic stem cells that circumvents the problem of cellular lethality of targeted mutations at essential loci. Using this approach, we have determined that mammalian DNA ligase I is essential for cell viability. Thus, DNA ligases II and III are not redundant with DNA ligase I for the function(s) associated with cell proliferation. Partial complementation of the lethal DNA ligase I null mutation allowed the creation of deficient embryonic stem cell lines. We found that a wild-type DNA ligase I cDNA, as well as a variant DNA ligase I cDNA, was able to rescue the lethality of the homozygous null mutation, whereas an N-terminal deletion mutant consisting of the minimal DNA ligase I catalytic domain was not. This observation demonstrates that sequences outside the DNA ligase I catalytic domain are essential for DNA ligase I function in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623824      PMCID: PMC230669          DOI: 10.1128/MCB.15.8.4303

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Identification of an origin of bidirectional DNA replication in mammalian chromosomes.

Authors:  W C Burhans; L T Vassilev; M S Caddle; N H Heintz; M L DePamphilis
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  Altered DNA ligase I activity in Bloom's syndrome cells.

Authors:  J Y Chan; F F Becker; J German; J H Ray
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

3.  DNA synthesis in Bloom's syndrome fibroblasts.

Authors:  K Fujikawa-Yamamoto; S Odashima; T Kurihara; F Murakami
Journal:  Cell Tissue Kinet       Date:  1987-01

4.  Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome.

Authors:  R G Langlois; W L Bigbee; R H Jensen; J German
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes.

Authors:  R S Chaganti; S Schonberg; J German
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

6.  Mammalian DNA ligases. Catalytic domain and size of DNA ligase I.

Authors:  A E Tomkinson; D D Lasko; G Daly; T Lindahl
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

7.  A mutant neomycin phosphotransferase II gene reduces the resistance of transformants to antibiotic selection pressure.

Authors:  R L Yenofsky; M Fine; J W Pellow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Complete enzymatic synthesis of DNA containing the SV40 origin of replication.

Authors:  Y Ishimi; A Claude; P Bullock; J Hurwitz
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

9.  Relation between the human fibroblast strain 46BR and cell lines representative of Bloom's syndrome.

Authors:  A R Lehmann; A E Willis; B C Broughton; M R James; H Steingrimsdottir; S A Harcourt; C F Arlett; T Lindahl
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

10.  Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles.

Authors:  P H Boer; H Potten; C N Adra; K Jardine; G Mullhofer; M W McBurney
Journal:  Biochem Genet       Date:  1990-06       Impact factor: 1.890

View more
  28 in total

1.  Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis.

Authors:  R S Maser; O K Mirzoeva; J Wells; H Olivares; B R Williams; R A Zinkel; P J Farnham; J H Petrini
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells.

Authors:  Y Xiao; D T Weaver
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

3.  Disconnecting XRCC1 and DNA ligase III.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

4.  A newly identified DNA ligase of Saccharomyces cerevisiae involved in RAD52-independent repair of DNA double-strand breaks.

Authors:  P Schär; G Herrmann; G Daly; T Lindahl
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

Review 5.  DNA-damage repair; the good, the bad, and the ugly.

Authors:  Razqallah Hakem
Journal:  EMBO J       Date:  2008-02-20       Impact factor: 11.598

Review 6.  Eukaryotic DNA ligases: structural and functional insights.

Authors:  Tom Ellenberger; Alan E Tomkinson
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

7.  Kinetic mechanism of human DNA ligase I reveals magnesium-dependent changes in the rate-limiting step that compromise ligation efficiency.

Authors:  Mark R Taylor; John A Conrad; Daniel Wahl; Patrick J O'Brien
Journal:  J Biol Chem       Date:  2011-05-10       Impact factor: 5.157

8.  Kinetic analyses of single-stranded break repair by human DNA ligase III isoforms reveal biochemical differences from DNA ligase I.

Authors:  Justin R McNally; Patrick J O'Brien
Journal:  J Biol Chem       Date:  2017-07-27       Impact factor: 5.157

9.  Specific inhibition of the eubacterial DNA ligase by arylamino compounds.

Authors:  G Ciarrocchi; D G MacPhee; L W Deady; L Tilley
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

10.  DNA ligase 1 deficient plants display severe growth defects and delayed repair of both DNA single and double strand breaks.

Authors:  Wanda M Waterworth; Jaroslav Kozak; Claire M Provost; Clifford M Bray; Karel J Angelis; Christopher E West
Journal:  BMC Plant Biol       Date:  2009-06-26       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.